In recent years, there has been an increasing incidence of inflammatory bowel disease in children and adolescents. Neurologic involvement has been mainly reported in adults, and information in pediatrics is based primarily on individual case reports. In this study, we explored the prevalence and spectrum of neurologic manifestations of 50 children with inflammatory bowel disease in comparison to healthy controls. Based on clinical reports and neurologic evaluation, 34 patients (68%) exhibited neurologic manifestations compared with 10 children (23.8%) in the control group (P < .001). The main symptoms associated with inflammatory bowel disease in comparison to the control subjects were headache: 46% vs 3% (P < 0.001), dizziness: 26% vs none (P < .001), hypotonia: 10% vs none (P = .06), attention-deficit hyperactivity disorder (ADHD): 28% vs 7.1% (P < .001), tics and sensory complaints: 16% vs 2.4% (P = .036). Seizures and neuropsychiatric disorders were less characteristic. A larger-scale prospective study is required to further clarify this association.
MamulaPMarkowitzJEBaldassanoRN. Inflammatory bowel disease in early childhood and adolescence: special considerations. Gastroenterol Clin North Am. 2003;32:967–995.
2.
KimSCFerryGD. Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations. Gastroenterology. 2004;126:1550–1560.
3.
BaldassanoRNPiccoliDA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am. 1999;28:445–458.
4.
AndresPGFriedmanLS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:255–281.
5.
DubinskyM. Special issues in pediatric inflammatory bowel disease. World J Gastroenterol. 2008;14:413–420.
6.
RothfussKSStangeEFHerrlingerKR. Extraintestinal manifestations and complications in IBD. World J Gastroenterol. 2006;12:4819–4831.
LossosARiverYEliakimASteinerI. Neurologic aspects of inflammatory bowel disease. Neurology. 1995;45:416–421.
9.
ZoisCDKatsanosKHKosmidouMTsianosEV. Neurologic manifestations in inflammatory bowel disease: current knowledge and novel insights. J Crohns Colitis. 2010;4:115–124.
10.
JoshiDDickelTAgaRSmith-LaingG. Stroke in inflammatory bowel disease: a report of two cases and review of the literature. Thromb J. 2008;6:2.
11.
TalbotRWHeppellJDozoisRRBeartRWJr. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986;61:140–145.
12.
MiehslerWReinischWValicE. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism. Gut. 2004;53:542–548.
13.
UmitHAsilTCelikY. Cerebral sinus thrombosis in patients with inflammatory bowel disease: a case report. World J Gastroenterol. 2005;11:5404–5407.
14.
PerkinGDMurray-LyonI. Neurology and the gastrointestinal system. J Neurol Neurosurg Psychiatry. 1998;65:291–300.
15.
RangEHBrookeBNHermon-TaylorJ. Association of ulcerative colitis with multiple sclerosis. Lancet. 1982;2:555.
16.
MinukGYLewkoniaRM. Possible familial association of multiple sclerosis and inflammatory bowel disease. N Engl J Med. 1986;314:586.
17.
SadovnickADPatyDWYannakouliasG. Concurrence of multiple sclerosis and inflammatory bowel disease. N Engl J Med. 1989;321:762–763.
18.
GeisslerAAndusTRothM. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet. 1995;345:897–898.
19.
GuptaGGelfandJMLewisJD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology. 2005;129:819–826.
20.
ChenMLeeGKwongLN. Cerebral white matter lesions in patients with Crohn's disease. J Neuroimaging. 2012;22:38–41.
21.
DruschkyAHeckmannJGDruschkyK. Severe neurological complications of ulcerative colitis. J Clin Neurosci. 2002;9:84–86.
22.
DubcencoEOttawayCAChenDLBakerJP. Neurological symptoms suggestive of demyelination in Crohn’s disease after infliximab therapy. Eur J Gastroenterol Hepatol. 2006;18:565–566.
23.
FreemanHJFlakB. Demyelination-like syndrome in Crohn's disease after infliximab therapy. Can J Gastroenterol. 2005;19:313–316.
24.
SinghSKumarNLoftusEVJrKaneSV. Neurologic complications in patients with inflammatory bowel disease: increasing relevance in the era of biologics. Inflamm Bowel Dis. 2013;19:864–872.
25.
RajendraSKadirZAKarimNZainZ. Ulcerative colitis and motor neuron disease: causal or coincidental. Singapore Med J. 2003;44:423–425.
26.
GondimFABrannaganTH3rdSanderHW. Peripheral neuropathy in patients with inflammatory bowel disease. Brain. 2005;128:867–879.
27.
YesilovaZNaharciIUygunA. Motor axonal polyneuropathy in the course of ulcerative colitis: a case report. Turk J Gastroenterol. 2006;17:58–61.
28.
GrecoFPavonePFalsaperlaR. Peripheral neuropathy as first sign of ulcerative colitis in a child. J Clin Gastroenterol. 2004;38:115–117.
29.
AkbayirNCalisABAlkimC. Sensorineural hearing loss in patients with inflammatory bowel disease: a subclinical extraintestinal manifestation. Dig Dis Sci. 2005;50:1938–1945.
30.
LarrodePRamonYCajalS. Peripheral neuropathy associated with intestinal inflammatory disease. Neurologia. 2001;16:133–137.
31.
OliveiraGRTelesBCBrasilEF. Peripheral neuropathy and neurological disorders in an unselected Brazilian population based cohort of IBD patients. Inflamm Bowel Dis. 2008;14:389–395.
32.
ScheidRTeichN. Neurologic manifestations of ulcerative colitis. Eur J Neurol. 2007;14:483–493.
33.
AkhanGAndermannFGotmanMJ. Ulcerative colitis, status epilepticus and intractable temporal seizures. Epileptic Disord. 2002;4:135–137.
34.
AkobengAKMillerVThomasAG. Epilepsy and Crohn's disease in children. J Pediatr Gastroenterol Nutr. 1998;26:458–460.
BridgerSEvansNParkerACairnsSR. Multiple cerebral venous thromboses in a child with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1997;25:533–536.
37.
Lloyd-StillJDTomasiL. Neurovascular complications of inflammatory bowel disease in childhood. J Pediatr Gastroenterol Nutr. 1989;9:461–466.
38.
ParadisKBernsteinMLAdelsonJW. Thrombosis as a complication of inflammatory bowel disease in children: a report of 4 cases. J Pediatr Gastroenterol Nutr. 1985;4:659–662.
39.
MarkowitzRLMentLRGryboskiJD. Cerebral thromboembolic disease in pediatric and adult inflammatory bowel disease: case report and review of the literature. J Pediatr Gastroenterol Nutr. 1989;8:413–420.
40.
ElsehetyABertoriniTE. Neurologic and neuropsychiatric complications of Crohn’s disease. South Med J. 1997;90:606–610.
IBD Working Group of the European Society for pediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis- the Porto criteria. J Pediatr Gastroentrol Nutr. 2005;41:1–7.
43.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV). 4th ed. Washington, DC: American Psychiatric Publishing; 1994.
44.
HaddockRGarrickVHorrocksIRussellR. A case of posterior reversible encephalopathy syndrome in a child with Crohn's disease treated with Infliximab. J Crohns Colitis. 2011;5:623–627.
45.
ZelnikNPachtAObeidRLernerA. Range of neurologic disorders in patients with celiac disease. Pediatrics. 2004;113:1672–1676.
46.
NiederhoferH. Association of attention deficit/ hyperactivity disorder and celiac disease: a brief report. Prim Care Companion CNS Disord. 2011;13.
47.
CadyRKFarmerKDexterJKHallJ. The bowel and migraine: update on celiac disease and irritable bowel syndrome. Curr Pain Headache Rep. 2012;16: 278–286.
48.
BrianiCZaraGAlaediniA. Neurological complications of celiac disease and autoimmune mechanisms: a prospective study. J Neuroimmunol. 2008;195: 171–175.
49.
WatkinsonG. Sulphasalazine: a review of 40 years' experience. Drugs. 1986;32:1–11.
50.
MahadevanUSandbornWJLiDK. Pregnancy outcome in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007;133:1106–1112.
